# The Evolution of Symbiosis in Staphylococcus epidermidis: From a Protective Mutualist to a Parasitic Pathogen

**Authors:** Stefanie Au, William Dela Cruz, Mehzabin Lala, Srinivasan Karthikeyan, Vishwanath Venketaraman

PMC · DOI: 10.3390/biom16020334 · Biomolecules · 2026-02-23

## TL;DR

Staphylococcus epidermidis evolved from a skin protector to a dangerous antibiotic-resistant pathogen through genetic changes and resistance gene transfer.

## Contribution

This paper reviews the genomic evolution and dual role of S. epidermidis as both a commensal and pathogen.

## Key findings

- S. epidermidis has evolved multidrug resistance through mechanisms like biofilm formation and gene transfer.
- Genomic islands and SCCmec elements contribute to its resistance and pathogenicity.
- Antibiotic misuse and hospital exposure have accelerated its genomic remodeling.

## Abstract

Staphylococcus epidermidis is more often known as a human skin commensal, serving as a primary protective bacterium on the skin’s surface. However, more recent literature highlights the role of S. epidermidis as a nosocomial pathogen and a multidrug-resistant organism that poses a global threat. The evolution of S. epidermidis can be owed to its accumulation of resistance mechanisms, including adhesion, biofilm formation, genomic islands, phage elements, integrated plasmids, and quorum sensing. It is suspected that through gene transfer, S. epidermidis is partially responsible for the feared multidrug-resistant Staphylococcus aureus through the mecA gene and many other genomic island transfers. Overall, prolonged nosocomial exposure and misuse of antibiotics have driven dramatic genomic remodeling in S. epidermidis, characterized by many methods of genetic recombination, SCCmec and insertion sequence acquisition, and accumulation of multiple resistance genes. Our review reviews the role of S. epidermidis as both a commensal and a pathogenic bacterium, summarizes the genes responsible for its multidrug resistance, and describes methods of combatting its invasion.

## Linked entities

- **Genes:** mecA (adaptor protein controlling oligomerization of the AAA+ protein ClpC) [NCBI Gene 936406]
- **Species:** Staphylococcus epidermidis (taxon 1282), Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** beta-lactamase [NCBI Gene 9086811]
- **Diseases:** hypotension (MESH:D007022), fever (MESH:D005334), infectious mastitis (MESH:D008413), periprosthetic joint infection (MESH:D057068), left ventricular assist device infection (MESH:D018487), staphylococcal (MESH:D011023), Netherton syndrome (MESH:D056770), dyspnea (MESH:D004417), DM (MESH:D003920), MRSE (MESH:D060467), injury to (MESH:D014947), inflammation (MESH:D007249), MDRSE (MESH:D018088), purulence (MESH:D003234), Fournier's gangrene (MESH:D018934), erythema (MESH:D004890), AD (MESH:D003876), CoNS (MESH:D013203), bloodstream infections (MESH:D018805), infectious (MESH:D003141), infectious endocarditis (MESH:D004696), S. epidermidis (MESH:D018455), MRSE infections (MESH:D007239), chills (MESH:D023341), osteitis (MESH:D010000), toxicity (MESH:D064420), nosocomial infections (MESH:D003428), seborrheic dermatitis (MESH:D012628), catheter (MESH:D055499), eczema (MESH:D004485)
- **Chemicals:** teichoic acid (MESH:D013682), fusidic acid (MESH:D005672), gentamicin (MESH:D005839), Chlorhexidine (MESH:D002710), Methicillin (MESH:D008712), erythromycin (MESH:D004917), ceramides (MESH:D002518), Vancomycin (MESH:D014640), Peptides (MESH:D010455), nucleotide (MESH:D009711), essential oil (MESH:D009822), levofloxacin (MESH:D064704), nafcillin (MESH:D009254), tetracyclines (MESH:D013754), CHG (MESH:C010882), polysaccharide (MESH:D011134), mupirocin (MESH:D016712), amoxicillin/clavulanic acid (MESH:D019980), ciprofloxacin (MESH:D002939), ceftaroline (MESH:C490727), PNAG (MESH:C505465), teicoplanin (MESH:D017334), cefoxitin (MESH:D002440), eucalyptus oil (MESH:D000078122), aminoglycoside (MESH:D000617), beta-lactam (MESH:D047090), N-acetylcysteine (MESH:D000111), povidone-iodine (MESH:D011206), glucose (MESH:D005947), ampicillin (MESH:D000667), Daptomycin (MESH:D017576), oxacillin (MESH:D010068), butyrate (MESH:D002087), macrolide (MESH:D018942), c-di-GMP (MESH:C062025), linezolid (MESH:D000069349), sodium hypochlorite (MESH:D012973), fatty acid (MESH:D005227), N-acetylglucosamine (MESH:D000117), Rifampin (MESH:D012293), C9 (-), cefotaxime (MESH:D002439), penicillin (MESH:D010406), tetracycline (MESH:D013752)
- **Species:** Macrococcoides caseolyticum (species) [taxon 69966], Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa (species) [taxon 287], Klebsiella pneumoniae (species) [taxon 573], Enterococcus faecium (species) [taxon 1352], Staphylococcus sp. E16 (species) [taxon 1082397], Acinetobacter baumannii (species) [taxon 470], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Staphylococcus epidermidis (species) [taxon 1282], Homo sapiens (human, species) [taxon 9606], Staphylococcus warneri (species) [taxon 1292]
- **Mutations:** I527M, G2602T, G2576T, D471E

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938455/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12938455/full.md

## References

92 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938455/full.md

---
Source: https://tomesphere.com/paper/PMC12938455